Concord Biotech Limited

We are thrilled to announce our strategic investment in CleanMax Enviro, bringing renewable energy to our Dholka facility. This initiative reflects our commitment to sustainability and reducing our carbon footprint. By transitioning to clean energy, we are not only contributing to a greener planet but also enhancing the operational efficiency of our facility. This step marks a significant milestone in our ongoing efforts to drive sustainable growth and meet evolving environmental standards. #Sustainability #RenewableEnergy #GreenEnergy #CarbonFootprint #Dholka #Ahemdabad #EnergyEfficiency #CleanEnergy #CleanMaxEnviro #ConcordBiotech

Transplantation has advanced greatly, improving short-term graft survival, yet long-term outcomes remain a challenge. New approaches in immunomodulation, reducing organ discard, and bioengineering offer hope, with personalized therapies set to transform the future of transplant success. Read more: https://lnkd.in/dzn_xNkD #Transplantation #organtransplant #solidorgantransplant #immunomodulation #personalizedmedicine #bioengineering #conquesthealth #concordbiotech

May the season of harvest bless you with abundance, prosperity, and happiness. Happy Makar Sankranti, Uttarayan, Pongal, and Bihu. #makarsankranti #pongal #uttarayan #bihu #festival #ConcordBiotech

May 2025 be a year of opportunities, achievements, and well-being. Concord Biotech wishes you a Happy New Year, filled with happiness and success. #HappyNewYear #NewYear #NewYearWishes #Celebration #Resolutions #Year2025 #ConcordBiotech #Healthcare

Wishing you a season filled with love, laughter, and cherished moments with your loved ones. Merry Christmas! #MerryChristmas #Christmas #Celebration #ChristmasVibes

Aplastic anemia (AA) treatment has transformed from a fatal diagnosis to one with survival rates exceeding 80–85%. Hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST) are now the primary treatments, with IST being more widely used. A key breakthrough was the introduction of antithymocyte globulin (ATG), which, when combined with cyclosporine, significantly improved treatment outcomes. The most effective current regimen for SAA includes horse ATG, cyclosporine, and eltrombopag, which represents a major advancement in AA management. This progress marks a significant improvement in outcomes for patients with this once-lethal disease. Read more: https://lnkd.in/d8gQDdgS #aplasticanemia #Anemia #management #Hematopoieticstemcelltransplantation #immunosuppressivetherapy #hematology

nvasive fungal infections (IFIs) are a serious concern for critically ill children, especially those with compromised immunity, with Candida being the leading cause, followed by Aspergillus, Zygomycetes, and Fusarium. The rise in resistant infections due to excessive antifungal use underscores the need for early diagnosis and appropriate treatment. This review examines the epidemiology, antifungal therapies, and dosing strategies to improve outcomes in this vulnerable population. #invasivefungalinfections #fungaldiseases #fungalinfection #antifungals #candida #Aspergillus #criticalcare #ICU #ConcordBiotech

Nosocomial pneumonia, driven by multi-drug-resistant Gram-negative bacteria, remains a leading cause of mortality in critically ill patients. With new antibiotics like ceftolozane-tazobactam and meropenem-vaborbactam offering hope, resistance remains a concern. Understanding the impact of altered lung physiology on drug delivery is key to improving treatment outcomes in severe infections. #Nosocomialpneumonia #multidrugresistant #gramnegativebacteria #criticalcare #ICU #Concordbiotech

This World AIDS Day, let’s join hands to break the stigma, promote prevention, and support those living with HIV/AIDS. #WorldAIDSDay #aidsawareness #StopHIVTogether #HIV #AIDS #preventioniscure

Seropositive rheumatoid arthritis (RA) results from a complex mix of genetic and environmental factors, often without a family history. At diagnosis, patients typically show joint inflammation and autoantibodies like ACPA and RF. Retrospective studies reveal that markers can appear years before symptoms. This study investigated factors influencing RA risk to better identify individuals at high or low risk for developing arthritis. Read more - https://lnkd.in/dhYpmQHc #RheumatoidArthritis #arthritis #Rheumatology #Symptoms #RA #ConcordBiotech #conquesthealth